XRAY Filing
4Filing Date: Jun 15, 2026

DENTSPLY SIRONA Inc. (XRAY) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0000818479-26-000211open_in_new
Total Value$100.0K
Trades1
Insiders1

Transaction Details

Gladden Brian T
Director·Direct
Buy · Acquire
Common Stock
Shares+9.99K
Price$10.02
Total Value$100.0K
Shares Owned After61.85K
Transaction DateJun 15, 2026
Footnotes ▸

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.015 to 10.0156, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Post-Transaction Holdings

Gladden Brian T
SecuritySharesChange
Common Stock61.85K+9.99K (19.25%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-15 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: DENTSPLY SIRONA Inc. (XRAY) CIK: 0000818479 --- Reporting Owner --- Name: Gladden Brian T CIK: 0001435432 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-15 | Code: P (Open market purchase) Shares: +9,985.022 | Price: $10.02 Total Value: $100,000.00 Shares Owned After: 61,848.544 | Ownership: D (Direct) Footnotes: [F1] The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.015 to 10.0156, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. --- Footnotes (Complete Index) --- F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.015 to 10.0156, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. --- Signature --- /s/ /s/ Jessica Nielsen Causey, Attorney-in-Fact for Brian T. Gladden (2026-06-15)

keid analysis is for reference only and does not constitute investment advice.